Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
June 7, 2022 at FDA Approves Once-Weekly Wegovy injection for the Treatment of Obesity in Teens Aged 12 Years and Older
High-dose oral versions of the medication in the weight-loss drug Wegovy may work as well as the popular injections when it comes to paring pounds and improving health, according to final results of two studies released Sunday night
Patients with polycystic ovary syndrome (PCOS) may experience indirect benefits from tirzepatide through weight reduction and subsequent improvements in insulin resistance, though this is not an FDA-approved indication and specific studies in this population remain limited
While the full long-term risk to humans is not yet known, the Black Box Warning exists due to concerning findings in animal studies and a lack of long-term human data
